Donnellan v. Lindner

CourtDistrict Court, M.D. Pennsylvania
DecidedMay 8, 2024
Docket3:23-cv-01728
StatusUnknown

This text of Donnellan v. Lindner (Donnellan v. Lindner) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Donnellan v. Lindner, (M.D. Pa. 2024).

Opinion

THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF PENNSYLVANIA PATRICIA DONNELLAN, Plaintiff, 3:23-CV-01728 : (JUDGE MARIANI) Vv. HENRY LINDNER, M.D., . Defendant. MEMORANDUM OPINION |. INTRODUCTION Defendant's Rule 12(b)(6) Motion to Dismiss and/or Motion to Strike Pursuant to Rule 12(f) (Doc. 7) is pending before the Court. With his Motion, Defendant asks the Court to strike all references to “reckless”, “wanton”, “outrageous”, and “grossly negligent conduct.” (/d. J 35.) Additionally, Defendant asks the Court to dismiss Plaintiffs requests for punitive damages and Intentional Infliction of Emotional Distress claim. (/d. at 7, 10.) The Plaintiff in the Complaint is Patricia Donnellan. (Doc. 1 J 4.) The Defendant is Henry Lindner, M.D. (/d. 75.) Plaintiffs Complaint (Doc. 1) alleges that Lindner diagnosed Plaintiff with babesiosis without confirmation that Plaintiff had any parasitic infection. Plaintiff also alleges that, because of this diagnosis, Lindner prescribed Plaintiff with numerous medications over a significant period of time that caused Plaintiff physical and emotional harm. Despite Plaintiff informing Lindner of the serious side effects that she was experiencing, Plaintiff alleges that Lindner continued to prescribe high dosages of the same

medication. Plaintiffs Complaint filed on October 17, 2023 contains two counts: Count | asserts a negligence claim under the Medical Care Availability and Reduction of Error Act (“MCARE’), 40 P.S. § 1303.505(a); and Count II asserts an Intentional Infliction of Emotional Distress claim. For the reasons explained below, the Court will deny Defendant's Motion (Doc. 7). Il. BACKGROUND! Plaintiff Patricia Donnellan (‘Plaintiff’) is an adult citizen of the State of Michigan. (Doc. 1 □ 4.) Defendant Henry Lindner, M.D. (“Lindner”) is an adult citizen of the Commonwealth of Pennsylvania. (/d. 5.) At all relevant times, Lindner was a physician licensed to practice medicine in the Commonwealth of Pennsylvania, holding himself out as

a practitioner in the areas of endocrinology and infectious disease. (/d.) Lindner maintained

a medical practice, office, and place of business at 230 West Tioga Steet, Suite 5, Tunkhannock, Pennsylvania, 18657. (/d.) In November 2008, Plaintiff was thirty-one (31) years old, and she presented to Lindner complaining of achiness, weight gain, depression, problems with her sleep, and other symptoms consistent with chronic fatigue. (/d. ] 6.) At all relevant times, Lindner advertised on a website, HormoneRestoration.com, which suggested that he could help restore energy and health to patients with Plaintiffs symptoms. (Doc. 1 7.)

Unless otherwise noted, the background information reiterates facts contained in Plaintiff's Complaint (Doc. 1).

HormaneResoration.com does not mention whether Lindner is board certified in any specialty. (/d. ¥ 8.) It states that he began a residency in psychiatry, but resigned after one

year and became a general medical officer and flight surgeon in the United States Air Force. (Id.) From 2008 to 2022, Plaintiff was a patient of Lindner’s and was under his care. (/d. 9.) Plaintiff met Lindner in person approximately three times during this period, and normally communicated with him by email, and occasionally by phone. (/d.) In and around December 2020, Lindner ordered testing to determine whether Plaintiff was infected by a babesia parasite, an infection caused by a babesia parasite is known as “babesiosis,” and can be caused in humans by a tick bite. (Doc. 1 10.) Babesia odocoilei is one particular species of the babesia parasite, and Lindner says that it causes chronic babesiosis infections in humans. (/d. J 11.) However, almost all cases of babesiosis in humans in the United States are caused by babesia microti, not babesia odocoilei. (Id.) Lindner has acknowledged that cases of human infection cases by babesia odocoilei are “unknown to mainstream medicine” and difficult to detect by laboratory testing. (/d.) Plaintiff alleges that it is standard practice for doctors in the United States to diagnose babesiosis using epidemiological risk factors and clinical evidence, and to confirm the diagnosis with a blood smear examination or polymerase chain reaction (PCR) test. □□□□ {| 12.) The testing that Lindner ordered in December 2020 included a PCR test, which was negative for both babesia microti and babesia duncani (another babesia species). (Doc. 1]

13.) The testing did produce a positive result for babesia duncani antibodies, but that result alone was not a sufficient basis for a reasonable doctor to diagnose an active infection of babesiosis, given the negative PCR test and absence of other laboratory confirmation. (/d.) No PCR test or blood smear examination ever confirmed that Plaintiff was infected with babesiosis. (/d. 14.) Nonetheless, Lindner diagnosed Plaintiff with babesiosis. (/d.) According to the Centers for Disease Control and Prevention (“CDC’), for non- immunosuppressed people, babesiosis is either asymptomatic or causes an acute illness, which should be confirmed through testing and treated for 7-10 days with antimicrobials, such as azithromycin and atovaquone. (/d. 15.) Lindner knew that mainstream medicine views babesiosis as an acute disease to be treated with a short course of antimicrobial medication. (/d. J 16.) Plaintiff claims that a reasonable physician does not prescribe antimicrobial medications for months or longer without a specifically identified objective rationale, confirmed by testing, because of the risk that the patient will develop antimicrobial resistance and other adverse side effects. (Doc. 1 q 17.) Despite not having a blood smear examination or PCR test result confirming that Plaintiff had babesiosis, Lindner prescribed antimicrobial medications to Plaintiff for mcre than twenty months. (/d. { 18.) Lindner knew that some of the medications he prescribed, such as tafenoquine, were not FDA approved for the treatment of babesiosis, or were not

routinely recommended by the CDC or the Infectious Diseases Society of America (“IDSA’). (Id. 19.) On April 20, 2021, Lindner emailed Plaintiff a document he wrote, titled “The Treatment of Chronic Babesiosis.” (/d. J 20.) The document showed that Lindner was aware that his treatment program for babesiosis would cause his patients to become more ill, with symptoms including fatigue, brain fog, headaches, muscle weakness, anxiety, and delirium. ({d.) Lindner convinced Plaintiff that the harm caused by babesia parasites was worse than the possible side effects she would experience. (Doc. 1 □ 21.) Plaintiff relied on Lindner’s diagnosis and treatment advice for babesiosis and followed his instructions with respect to the medications he prescribed and the dosing of those medications. (/d. J 22.) Plaintiff relied on Lindner’s diagnosis and treatment advice for babesiosis in part because Lindner told Plaintiff that he had diagnosed babesiosis in his own daughter, and he had developed the treatment program for her. (/d. ¥ 23.) Lindner prescribed Plaintiff and other babesiosis patients high doses of corticosteroids, including prednisone, hydrocortisone, and dexamethasone, which he claimed could address the inflammation patients experienced as a result of the antimicrobial medication. (/d. {| 24.) Lindner prescribed corticosteroids for Plaintiff between 2008 and 2020 to treat the symptoms for which she originally sought his medical care. (Id. 25.)

During these years, Plaintiff's corticosteroid doses rarely exceeded the equivalent of 20 milligrams of prednisone per day. (/d.) Between December 2020 and November 2022, Plaintiff took the additional medications prescribed by Lindner as part of his babesiosis protocol, which included even higher doses of corticosteroids than those previously prescribed. (Doc.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
Santiago v. Warminster Township
629 F.3d 121 (Third Circuit, 2010)
Burtch v. Milberg Factors, Inc.
662 F.3d 212 (Third Circuit, 2011)
Ethypharm S.A. France v. Abbott Laboratories
707 F.3d 223 (Third Circuit, 2013)
Connelly v. Steel Valley School District
706 F.3d 209 (Third Circuit, 2013)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
North Penn Transfer, Inc. v. Victaulic Co. of America
859 F. Supp. 154 (E.D. Pennsylvania, 1994)
Toney v. Chester County Hospital
961 A.2d 192 (Superior Court of Pennsylvania, 2008)
Fewell v. Besner
664 A.2d 577 (Superior Court of Pennsylvania, 1995)
Kazatsky v. King David Memorial Park, Inc.
527 A.2d 988 (Supreme Court of Pennsylvania, 1987)
Banyas v. Lower Bucks Hospital
437 A.2d 1236 (Superior Court of Pennsylvania, 1981)
PAPIEVES Et Ux. v. Kelly
263 A.2d 118 (Supreme Court of Pennsylvania, 1970)
Hoy v. Angelone
720 A.2d 745 (Supreme Court of Pennsylvania, 1998)
Crivellaro v. Pennsylvania Power & Light Co.
491 A.2d 207 (Supreme Court of Pennsylvania, 1985)
Swisher v. Pitz
868 A.2d 1228 (Superior Court of Pennsylvania, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Donnellan v. Lindner, Counsel Stack Legal Research, https://law.counselstack.com/opinion/donnellan-v-lindner-pamd-2024.